{"id":777,"date":"2026-10-14T06:27:29","date_gmt":"2026-10-14T06:27:29","guid":{"rendered":"https:\/\/gscn.sleware.com\/gscn-conferences\/previous-gscn-conferences\/gscn-conference-2025\/program-speakers-2025\/"},"modified":"2026-10-14T06:32:07","modified_gmt":"2026-10-14T06:32:07","slug":"program-speakers-2025","status":"publish","type":"page","link":"https:\/\/gscn.sleware.com\/gscn-conferences\/previous-gscn-conferences\/gscn-conference-2025\/program-speakers-2025\/","title":{"rendered":"Program & Speakers 2025"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\"\"<\/p>\n\n

\n\n \n \n
  <\/span>Program<\/a>  <\/span><\/span><\/strong><\/td>\n   Registration<\/u><\/a><\/span> <\/span><\/span><\/strong><\/td>\n <\/tr>\n <\/tbody>\n<\/table>\n<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Program<\/h1>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Download the short program \"\" here<\/a> or only the agenda \"\" here<\/a>;
\nthe complete program (including abstracts) can be downloaded \"\" here<\/a>.<\/p>\n\n

\n
\n\n \n \n
Wednesday<\/a><\/td>\n Thursday<\/a><\/td>\n Friday<\/a><\/td>\n <\/tr>\n <\/tbody>\n<\/table>\n<\/div>\n\n

Wednesday, 15 October 2025<\/strong><\/h2>\n\n
\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
11:00 – 11:30
\n Plenary Hall<\/td>\n 		Opening<\/strong><\/span>
\n GSCN Conference 2025<\/strong><\/td>\n <\/tr>\n
11:00 – 11:15<\/td>\n Welcome Helmholtz Munich
\n Martin Hrab\u011b de Angelis, <\/em>Research Director Hemholtz Munich<\/td>\n <\/tr>\n
11:15 – 11:30<\/td>\n Opening of GSCN Conference 2025 
\n Heiko Lickert<\/em>, President GSCN<\/td>\n <\/tr>\n
11:30 – 12:15
\n Plenary Hall<\/td>\n 		Keynote lecture I                   <\/strong>supported by FUJIFILM Wako Chemicals Europe<\/span><\/span>
\n K1 – Advances in cell therapy for Parkinson's disease: Insights from the results of a phase 1 trial and future directions
\n Viviane Tabar<\/em>, Memorial Sloan Kettering Cancer Center, New York, USA
\n Chair: Oliver Br\u00fcstle<\/i><\/td>\n <\/tr>\n
12:15 – 13:00
\n Plenary Hall<\/td>\n 		Keynote lecture II<\/strong>
\n K2 – Long-term single live cell quantification: New tools for old questions
\n Timm Schroeder<\/em>, Biosystems Science and Engineering (BSEE), ETH Z\u00fcrich, Basel, Switzerland
\n Chair: Claudia Waskow<\/em> <\/td>\n <\/tr>\n
13:00 – 14:30
\n Mensa<\/span><\/td>\n 		Lunch break \/ Industry exhibition<\/span>    <\/td>\n <\/tr>\n
14:30 – 16:00<\/td>\n Concurrent scientific working group session I<\/strong><\/td>\n <\/tr>\n
14:30 – 16:00
\n Plenary Hall<\/td>\n 		Stem cells in regenerative therapies<\/strong>                  supported by Eppendorf<\/span><\/span>
\n Chairs: Ulrich Martin & Wolfgang Wagner<\/em><\/td>\n <\/tr>\n
14:30 – 15:00<\/td>\n T01 – Therapeutic CAR-T cell products: What can we learn for pluripotent stem cell based products?
\n Ulrike K\u00f6hl<\/em>, Fraunhofer IZI, Leipzig<\/td>\n <\/tr>\n
15:00 – 15:15<\/td>\n T02 – Maximizing gene editing efficiency for enhanced clinical-grade iPSCs via sequential factor delivery
\n Thomas Berger<\/em>, Catalent, Langenfeld<\/td>\n <\/tr>\n
15:15 – 15:30<\/td>\n T03 – Off the shelf immune-shielded stem cell-derived macrophages for clinical applications
\n Stefanie Pfaender<\/em>, Evotec, Cell Therapy, G\u00f6ttingen<\/td>\n <\/tr>\n
15:30 – 15:45<\/td>\n T04 – Prototypical ten-week end-to-end process for autologous Parkinson's disease cell therapy
\n Diana Haberhausen<\/em>, Miltenyi Biotec, Bergisch Gladbach<\/td>\n <\/tr>\n
15:45 – 16:00<\/td>\n T05 – Enhancing stem cell derived beta cell survival in hypoxia and nutrient deprivation with small molecules
\n V\u00e4in\u00f6 Lithovius<\/em>, Helmholtz Diabetes Center, Munich<\/td>\n <\/tr>\n
14:30 – 16:00
\n SR1050<\/td>\n 		Tissue-derived stem cells  & organoids           <\/strong>supported by Sartorius<\/span><\/span>
\n Chairs: Sina Bartfeld & Anne Grapin-Botton<\/em><\/td>\n <\/tr>\n
14:30 – 15:00<\/td>\n T06 – Mapping the transcriptome and DNA-methylome at the single cell level decodes stemness across the young and injured brain
\n Ana Martin-Villalba<\/em>, DKFZ Heidelberg<\/td>\n <\/tr>\n
15:00 – 15:15<\/td>\n T07 – Manipulation of global protein translation rates and stem cell self-renewal by CRISPR mediated activation of rRNA transcription
\n Stefan Stricker<\/em>,  LMU & Helmholtz Munich<\/td>\n <\/tr>\n
15:15 – 15:30<\/td>\n T08 – Slit–Robo signaling controls early liver zonation during fetal development
\n Dominic Gr\u00fcn<\/em>, W\u00fcrzburg Institute of Systems Immunology<\/td>\n <\/tr>\n
15:30 – 15:45<\/td>\n T09 –  Unveiling human cardiac regenerative mechanisms in iPSC-derived epicardioids
\n Tobias Ellinger<\/em>, TUM Munich<\/td>\n <\/tr>\n
15:45 – 16:00<\/td>\n T10 – Human-specific morphoregulatory signatures in basal radial glia characterize neocortex evolution
\n Mareike Albert<\/em>, TU Dresden<\/td>\n <\/tr>\n
14:30 – 16:00
\n LH23<\/td>\n 		Stem cells in disease modeling & drug development I<\/strong>
\n Chairs: Oliver Br\u00fcstle & Harald Stachelscheid       <\/em>supported<\/span> <\/i>by Evotec SE<\/span><\/span>   <\/em> <\/td>\n <\/tr>\n
14:30 – 15:00<\/td>\n T11 – Epicardioids: Bridging cardiac development with disease and therapy
\n Alessandra Moretti<\/em>, TUM School of Medicine and Health, Munich<\/td>\n <\/tr>\n
15:00 – 15:15<\/td>\n T12 – AI-guided protein design of synthetic growth factor mimetics
\n Thomas Schlichth\u00e4rle<\/em>, TUM School of Natural Science, Munich<\/td>\n <\/tr>\n
15:15 – 15:30<\/td>\n T13 – Enhanced fibrosis modeling in human skin organoids through hiPSC-derived macrophage integration
\n Amelie Reigl<\/em>, Fraunhofer Institute for Silicate Research (ISC), W\u00fcrzburg<\/td>\n <\/tr>\n
15:30 – 15:45<\/td>\n T14 – Heart organoids and engineered heart tissue as hiPSC-derived in vitro models for Fabry cardiomyopathy
\n Anna Reinelt<\/em>, University hospital Eppendorf (UKE), Hamburg<\/td>\n <\/tr>\n
15:45 – 16:00<\/td>\n T15 – iPSC-driven drug discovery identifies sildenafil as a drug candidate for the mitochondrial disease Leigh syndrome
\n Annika Zink<\/em>, University hospital D\u00fcsseldorf<\/td>\n <\/tr>\n
16:00 – 16:30
\n CC & Build23<\/span><\/td>\n 		Break time \/ Industry exhibition  <\/span>   <\/td>\n <\/tr>\n
16:30 – 17:30
\n LH23<\/td>\n 		General Member Meeting<\/strong>
\n Executive Board & Managing Director
\n Heiko Lickert, Claudia Waskow, Sina Bartfeld, Michael Cross, Daniel Besser (excused Andreas Trumpp)<\/em><\/td>\n <\/tr>\n
17:30 – 19:30
\n Build23
\n  <\/td>\n 		Poster session I<\/strong> –<\/span> Poster number P001 – P072<\/span>       supported by Biomerieux<\/span><\/span>
\n (with beverages)<\/span>
\n Basic, translational & applied hematopoiesis: P001 – P006
\n Pluripotency, differentiation & PSC-derived models: P007 – P047
\n Stem cells in aging & disease (cancer stem cells): P048 – P051
\n Tissue-derived stem cells & organoids: P052 – P072<\/span>
\n
\n Even numbers: 17:30 – 18:30
\n Odd numbers: 18:30 – 19:30<\/span><\/strong><\/td>\n <\/tr>\n
19:45 -20:30
\n Plenary Hall<\/td>\n 		Keynote lecture III (on ELSA topics)<\/strong>
\n K3 – Synthetic ex utero embryogenesis: From naive pluripotent stem cells to bona fide embryo models
\n Jacob Hanna<\/em>, Weizmann Institute of Science, Rehovot, Israel
\n Chair: Tobias Cantz<\/em> <\/td>\n <\/tr>\n
20:30 – 22:00
\n Mensa<\/span><\/td>\n 		GSCN Get-together for all participants   <\/span>supported by FUJIFILM Wako Chemicals<\/span><\/span>
\n Dinner buffet<\/span><\/td>\n <\/tr>\n <\/tbody>\n
 <\/td>\n Top<\/a><\/td>\n <\/tr>\n <\/tbody>\n<\/table>\n<\/div>\n\n

 <\/p>\n<\/div>\n<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

<\/span><\/p>\n\n

Thursday, 16 October 2025<\/h2>\n\n
 \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n <\/tbody>\n<\/table>\n<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

<\/span><\/p>\n\n

Friday, 17 October 2025<\/h2>\n\n
\n

09:00 – 10:30<\/td>\n Concurrent scientific working group session II<\/strong><\/td>\n <\/tr>\n
09:00 – 10:30
\n Plenary Hall<\/td>\n 		Basic, translational & applied hematopoiesis<\/strong>      <\/span>supported <\/span><\/span>
\n Chairs: Nina Cabezas-Wallscheid & Michael Milsom    <\/em>by Thermo Fisher<\/span><\/span><\/td>\n <\/tr>\n
09:00 – 09:30<\/td>\n T16 – Blood stem cell expansion: Technology to biology
\n Adam Wilkinson<\/em>, Cambridge Stem Cell Institute, UK<\/td>\n <\/tr>\n
09:30 – 09:45<\/td>\n T17 – C57BL\/6 Kit-mutant immunodeficient mouse models uncover mechanism of successful hematopoietic stem cell xenotransplantation
\n Julia Fr\u00f6bel<\/em>, Leibniz Institute on Aging – FLI, Jena<\/td>\n <\/tr>\n
09:45 – 10:00<\/td>\n T18 – From codons to blood: A new perspective on hematopoietic differentiation
\n Marius K\u00fclp<\/em>, Goethe University, Frankfurt<\/td>\n <\/tr>\n
10:00 – 10:15<\/td>\n T19 – Multimodal omics identify an age resilient multipotent progenitor population that preserves youthful identity and function in the hematopoietic system
\n Mari Carmen Romero-Mulero<\/em>, ETH Zurich, CH<\/td>\n <\/tr>\n
10:15 – 10:30<\/td>\n T20 – Development of accessible ex vivo culture models of the human hematopoietic bone marrow niche
\n Sigrid Uxa<\/em>, University Leipzig<\/td>\n <\/tr>\n
09:00 – 10:30
\n SR1050<\/td>\n 		TACTiC symposium on iPSC-based heart repair<\/strong>
\n BMBF-funded project "Tailored Application for individualized Cell Therapy with iPSC-derived Cardiomyocytes (TACTiC)"
\n Chairs: <\/span>Ulrich Martin & Robert Zweigerdt<\/em><\/td>\n 		 <\/td>\n <\/tr>\n
09:00 – 09:30<\/td>\n T21 – Deep immune-phenotyping of HLA-homozygous iPS-cardiomyocytes
\n Dirk Strunk<\/em>, PMU Salzburg, Austria<\/td>\n <\/tr>\n
09:30 – 10:00<\/td>\n T22 – Biological-engineering and application of a myocardial patch
\n Joost <\/em>Sluijter,<\/em> UMC Utrecht, The Netherlands<\/td>\n <\/tr>\n
10:00 – 10:15<\/td>\n T23 – Large-scale production of human pluripotent stem cell–derived cardiomyocytes
\n Kevin Cyrys<\/em>, MH Hannover<\/td>\n <\/tr>\n
10:15 – 10:30<\/td>\n T24 – Automated myocardial cell injection
\n Raphael M\u00f6nkem\u00f6ller<\/em>, LU Hannover<\/td>\n <\/tr>\n
09:00 – 10:30
\n LH23<\/td>\n 		Pluripotency, differentiation & PSC-derived models I<\/strong>
\n Chairs: Mina Gouti & Hans Sch\u00f6ler<\/em><\/td>\n <\/tr>\n
09:00 – 09:30<\/td>\n T25 – Developing a safe and immune-evasive stem cell source for off-the-shelf therapeutic products
\n Andras Nagy<\/em>, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada<\/td>\n <\/tr>\n
09:30 – 09:45<\/td>\n T26 – Lineage single-cell multi-omics identify novel regulators and barriers in iPSC reprogramming
\n Angeliki Spathopoulou<\/em>, University of Innsbruck, Austria<\/td>\n <\/tr>\n
09:45 – 10:00<\/td>\n T27 – You shall not pass – functional pluripotency testing using hiPSCore
\n Jochen Dobner<\/em>, Leibniz-Institut f\u00fcr umweltmedizinische Forschung (IUF) D\u00fcsseldorf<\/td>\n <\/tr>\n
10:00 – 10:15<\/td>\n T28 – PluripotencyScreen – quantification of early cell fate decisions of iPSC based on DNA methylation
\n Kira Zeevaert<\/em>, UK RWTH Aachen<\/td>\n <\/tr>\n
10:15 – 10:30<\/td>\n T29 – Does gene dosage influence cell fate during human gastrulation?
\n Theresa Gross-Thebing<\/em>, Gurdon Institute, Cambridge, UK<\/td>\n <\/tr>\n
09:00 – 10:30
\n HPC<\/td>\n 		Stem cells in disease modeling & drug development II<\/strong>       
\n Chairs: Jan Eickhoff & Karl-Ludwig Laugwitz   <\/em>supported <\/span><\/span>by Bio-Techne<\/span><\/span><\/td>\n <\/tr>\n
09:00 – 09:30<\/td>\n T30 – Modulating reactive astrocytes in Alzheimer’s disease
\n Bastian Zimmer<\/em>, Evotec SE, Hamburg<\/td>\n <\/tr>\n
09:30 – 09:45<\/td>\n T31 – Evaluating the potential of Bruton’s tyrosine kinase inhibitors to modulate microglial inflammation to attenuate multiple sclerosis progression
\n Alica Blenkle<\/em>, Fraunhofer ITMP, G\u00f6ttingen<\/td>\n <\/tr>\n
09:45 – 10:00<\/td>\n T32 – A reproducible human brain tissue model to study physiological and disease-associated microglia phenotypes
\n Dominik Paquet<\/em>, LMU Munich<\/td>\n <\/tr>\n
10:00 – 10:15<\/td>\n T33 – Integration of CNTNAP2-deficient neurons into defined E\/I networks unmasks functional pathophenotypes
\n Jasmin Aicher<\/em>, University of Bonn<\/td>\n <\/tr>\n
10:15 – 10:30<\/td>\n T34 – Capturing disease severity in LIS1-lissencephaly reveals proteostasis dysregulation in patient-derived forebrain organoids
\n Matteo Gasparotto<\/em>, ZI Mannheim<\/td>\n <\/tr>\n
09:00 – 10:30
\n HPC-VIP<\/td>\n 		ELSA symposium<\/strong> 
\n Panel: Jacob Hanna<\/em>, and Maria-Elena Torres-Padilla;<\/em> Moderation: Tobias Cantz<\/em><\/td>\n <\/tr>\n
10:30 – 11:00
\n CC & Build23<\/span><\/td>\n 		Break time \/ Industry exhibition <\/span>                        <\/strong>supported by Minaris<\/span><\/span><\/td>\n <\/tr>\n
11:00 – 12:45<\/td>\n Industry session: "Technologies from GSCN industry partners"<\/strong><\/td>\n <\/tr>\n
11:00 – 12:35
\n Plenary Hall<\/td>\n 		Main Supporter<\/strong>
\n Chairs: Magdalena G\u00f6tz & Hartmut Geiger<\/em><\/td>\n <\/tr>\n
11:05 – 11:30<\/td>\n C01 – Tackling leachables in stem cell bioprocessing: Ensuring safety and scalability in single-use systems for clinical studies
\n Philipp Nold<\/em>, Eppendorf SE<\/td>\n <\/tr>\n
11:30 – 12:10<\/td>\n C02 – Advance your research with genetically diverse human induced pluripotent stem cell-derived models and a novel mRNA-lipid nanoparticle platform to rapidly generate functional forebrain neurons
\n Katharina Debowski<\/i>, STEMCELL Technologies GmbH<\/td>\n <\/tr>\n
12:10 -12:35<\/td>\n C03 – Forging the future of regenerative medicine with synthetic peptide growth factors
\n Robert Brownlee, <\/em>Opes Diagnostics<\/td>\n <\/tr>\n
11:00 – 12:45
\n SR1050<\/td>\n 		Supporter II<\/strong>
\n Chairs: Hannes Klump & Ana Martin-Villalba<\/em><\/td>\n <\/tr>\n
11:05 – 11:25<\/td>\n C04 – Approaches for optimizing pluripotent stem cell spheroid expansion in multi-liter bioreactors through the use of constant medium perfusion
\n David Kuninger<\/em>, Thermo Fisher Scientific<\/td>\n <\/tr>\n
11:25 – 11:45<\/td>\n C05 – The world's fastest PCR-based mycoplasma detection assay
\n Sabine Hahnau-Jurth<\/em>, Biomerieux Deutschland GmbH<\/td>\n <\/tr>\n
11:45 – 12:05<\/td>\n C06 – Enabling reliable PSC culture for advanced research applications
\n Hannah Johannsen<\/em>, Miltenyi Biotech B.V. & Co. KG<\/td>\n <\/tr>\n
12:05 – 12:25<\/td>\n C07 – The role of full-length laminins in enhancing in vitro cellular microenvironments
\n Chiara Annunziata\u200b,<\/em> BioLamina<\/td>\n <\/tr>\n
12:25 – 12:45<\/td>\n C08 – Live-cell 3D cell imaging innovations
\n Marco Benkisser-Petersen<\/em>, Sartorius <\/td>\n <\/tr>\n
11:00 – 12:25
\n LH23<\/td>\n 		Supporter III<\/strong>
\n Chairs:  Thomas Braun & Andreas Kurtz<\/em><\/td>\n <\/tr>\n
11:05 – 11:25<\/td>\n C09 – Recent advancements in gentle single-cell handling: The iotaSciences way
\n Matthias Hoja<\/em>, iotaSciences<\/td>\n <\/tr>\n
11:25 – 11:45<\/td>\n C10 – Alt-R™ CRISPR capabilities to accelerate your next breakthrough
\n Katarzyna Julia Duda<\/em>, Integrated DNA Technologies <\/td>\n <\/tr>\n
11:45 – 12:05<\/td>\n C11 – Cell therapy at Evotec – end-to-end from process development to clinical manufacturing
\n Matthias Austen<\/em>, Evotec<\/td>\n <\/tr>\n
12:05 – 12:25<\/td>\n C12 – What we've discovered: Opening Pandora's box of genomic mutations using NGS technology
\n Reda Zenagui<\/em>, Stem Genomics<\/td>\n <\/tr>\n
11:00 – 12:30
\n HPC<\/td>\n 		Supporter IV<\/strong>
\n Chairs:  Zoltan Ivics & Thomas Schwarz-Romond<\/em><\/td>\n <\/tr>\n
11:05 – 11:25<\/td>\n C13 – Commercial media formulations vs chemically defined home-brewed media for iPSC maintenance
\n Liz Stewart<\/em>, Qkine <\/td>\n <\/tr>\n
11:25 – 11:45<\/td>\n C14 – A global vision for cell and gene therapies
\n Karin Abitorabi<\/em>, Minaris<\/td>\n <\/tr>\n
11:45 – 12:05<\/td>\n C15 – Reliable 3D cell models – high-yield cultivation meets precision sorting
\n Markus Uhrig<\/em>, OLS OMNI Life Science <\/td>\n <\/tr>\n
12:05 – 12:25<\/td>\n C16 – Enhancing reproducibility in stem cell and organoid research: Strategies for consistent culture and characterization
\n Volker Arps<\/em>, Bio-Techne<\/td>\n <\/tr>\n
12:45 – 14:00
\n Mensa<\/span><\/td>\n 		Lunch break \/ Industry exhibition<\/span>                supported by IDT Germany GmbH<\/span><\/span><\/td>\n <\/tr>\n
14:00 – 16:15
\n Plenary Hall<\/td>\n 		Presidential Symposium<\/strong>
\n Chair: Heiko Lickert<\/em> & Claudia Waskow<\/em><\/td>\n <\/tr>\n
14:00 – 14:45<\/td>\n Presidential Invite<\/strong><\/span>
\n PS1 – Translation of tissue engineered heart repair
\n Wolfram-Hubertus Zimmermann<\/em>, University Hospital G\u00f6ttingen<\/td>\n <\/tr>\n
14:45 – 15:15<\/td>\n GSCN 2025 Young Investigator Award<\/strong><\/span>
\n PS2 – Molecular regulation of mammalian dormancy
\n Aydan Bulut-Karsl\u0131o\u011flu<\/em>, Max Planck Institute of Molecular Genetics, Berlin<\/td>\n <\/tr>\n
15:15 – 15:45<\/td>\n GSCN 2025 Hilde Mangold Award<\/strong><\/span>
\n PS3 – Harnessing RNA modifications for cancer therapies
\n Michaela Frye<\/em>, DKFZ, Heidelberg<\/td>\n <\/tr>\n
15:45 – 16:15<\/td>\n GSCN Publication of the Year 2024 – 2025 Award<\/strong><\/span>
\n PS4 – The role of safeguard repressors in cancer
\n Bryce Lim<\/em>, Moritz Mall<\/em>, DKFZ, Heidelberg<\/td>\n <\/tr>\n
16:15 – 16:30
\n CC & Build23<\/span><\/td>\n 		Break time \/ Industry exhibition <\/span>                                      supported by Biolamina<\/span><\/span><\/td>\n <\/tr>\n
16:30 – 18:30
\n Build23<\/td>\n 		Poster session II<\/strong> – Poster number P073 – P144 <\/span> supported by Miltenyi<\/span>
\n (with beverages)
\n Computational stem cell biology: P073 – P081
\n Stem cells in disease modeling & drug dev.: P082 – P124
\n Stem cells in regenerative therapies: P125 – P144<\/span><\/span>
\n
\n Even numbers: 16:30 – 17:30
\n Odd number: 17:30  – 18:30<\/strong><\/span><\/td>\n <\/tr>\n
19:00 – 01:00<\/span><\/td>\n GSCN networking event for all participants
\n                                                                   <\/strong><\/span>supported by STEMCELL Technologies<\/span><\/span><\/strong>
\n The entrance fee is collected on site
\n Event location: <\/span>\u279a<\/span> Gasthof Neuwirt, Garching<\/b><\/a>
\n M\u00fcnchener Str.10
\n 85748 Garching\u200b<\/span><\/td>\n <\/tr>\n <\/tbody>\n
\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
09:00 – 10:30<\/td>\n Concurrent scientific working group session III<\/strong><\/td>\n <\/tr>\n
09:00 – 10:30
\n Plenary Hall<\/td>\n 		Stem cells in aging & disease<\/strong>
\n Chairs: Hartmut Geiger & Simon Haas<\/em><\/td>\n <\/tr>\n
09:00 – 09:30<\/td>\n T35 – Tracing clonal architecture and differentiation trajectories in cancer using single cell barcoding
\n Michael Rieger<\/em>, Goethe University Frankfurt<\/td>\n <\/tr>\n
09:30 – 09:45<\/td>\n T36 –  Role of aging and environmental stress in the decline of lung stem cell function and regenerative capacity
\n Maja Funk<\/em>, Helmholtz Munich<\/td>\n <\/tr>\n
09:45 – 10:00<\/td>\n T37 – Investigating aging and telomere biology in lung disease using induced pluripotent stem cell derived models
\n Mari Ozaki<\/em>, Royal College of Surgeons (RCSI), Dublin, Ireland<\/td>\n <\/tr>\n
10:00 – 10:15<\/td>\n T38 – High fat diet affects the stromal niche signaling in the porcine intestine
\n Falk Farkas<\/em>, Helmholtz Munich<\/td>\n <\/tr>\n
10:15 – 10:30<\/td>\n T39 – TET2-mutant clonal hematopoiesis drives inflammation-associated hepatocarcinogenesis in a murine NAFLD model
\n Sena Alptekin<\/em>, DKFZ\/HI-STEM Heidelberg<\/td>\n <\/tr>\n
09:00 – 10:30
\n SR1050<\/td>\n 		DZL\/Breath symposium: Stem cells in lung research<\/strong>
\n Chair: Ruth Olmer & Paolo Panza<\/em><\/td>\n 		 <\/td>\n <\/tr>\n
09:00 – 09:30<\/td>\n T40 – Modelling type 2 alveolar epithelial cell biology and disease using patient-derived iPSC
\n Killian Hurley,<\/em> RCSI, Ireland<\/td>\n <\/tr>\n
09:30 – 09:45<\/td>\n T41 – Sotatercept as a novel therapy for pulmonary arterial hypertension: Attenuation of fibrosis and contractility in iPSC-derived smooth muscle cells
\n Aileen Schmidt<\/em>, MH Hannover<\/td>\n <\/tr>\n
09:45 – 10:00<\/td>\n T42 – The lung microvasculature promotes alveolar type 2 cell differentiation via secreted SPARCL1
\n Paolo Panza, <\/em>UKGM, Gie\u00dfen<\/td>\n <\/tr>\n
10:00 – 10:15<\/td>\n T43 – Differentiation of airway epithelial basal cells into organotypic mucociliary tissues
\n Janna Nawroth<\/em>, TU Munich<\/td>\n <\/tr>\n
10:15 – 10:30<\/td>\n T44 – From injury to insight: Aberrant basaloid cells and the fortuitous discovery of a regeneration-associated cell state
\n Jonas Schupp, <\/em>MH Hannover<\/td>\n <\/tr>\n
09:00 – 10:30
\n LH23<\/td>\n 		Pluripotency, differentiation & PSC-derived models II<\/strong>       <\/span><\/span>
\n Chairs: Ralf Jauch<\/em> & Christian Schr\u00f6ter<\/em>          <\/em>supported by<\/span><\/span> OMNI Life Science <\/span><\/span><\/span><\/td>\n <\/tr>\n
09:00 – 09:15<\/td>\n T45 – Wnt\/Planar cell polarity signaling orchestrates ciliogenesis and cell-cycle exit during endocrine lineage commitment
\n Tobias Greisle<\/em>, Helmholtz Munich <\/td>\n <\/tr>\n
09:15 – 09:30<\/td>\n T46 – Single-cell multiome uncovers differences in glycogen metabolism underlying species-specific speed of development
\n Christian Schr\u00f6ter,<\/em> Leiden Academic Center, NL <\/td>\n <\/tr>\n
09:30 – 09:45<\/td>\n T47 – NSD1 governs H3K36me2-mediated DNA methylation and drives differentiation of human iPSCs by regulating ‘HIDEN’ lncRNA expression
\n Deepika Puri<\/em>, UK Aachen<\/td>\n <\/tr>\n
09:45 – 10:00<\/td>\n T48 – Patient-specific gene correction in LMNA-linked cardiomyopathy using 3D hiPSC-derived heart-tissues and native myocardial slices
\n Eleonore Baier<\/em>, TUM Munich<\/td>\n <\/tr>\n
10:00 – 10:15<\/td>\n T49 – 3D transcriptomic reconstruction highlights human heart-forming organoid development as a model of early organogenesis
\n Liam Wilson<\/em>, MH Hannover<\/td>\n <\/tr>\n
09:00 – 10:30
\n HPC<\/td>\n 		Computational stem cell biology<\/strong>                 <\/span><\/span>
\n Chairs: Ingmar Glauche & Carsten Marr<\/em><\/td>\n <\/tr>\n
09:00 – 09:30<\/td>\n T50 – Digital reprogramming decodes epigenetic barriers of cell fate changes
\n Eva H\u00f6rmanseder<\/em>, Helmholtz Munich <\/td>\n <\/tr>\n
09:30 – 09:45<\/td>\n T51 – Reinforcement learning for relapse prediction from sparse measurements in exponentially progressing disease
\n Arina Shelashen<\/em>, TU Dresden<\/td>\n <\/tr>\n
09:45 – 10:00<\/td>\n T52 – Uncovering transcriptional drivers of cell identity with generative modeling and high-throughput reprogramming
\n Mariia Minaeva<\/em>, Helmholz Munich<\/td>\n <\/tr>\n
10:00 – 10:15<\/td>\n T53 – High resolution spatio-temporal mapping reveals dedifferentiation niches in mammalian cardiac repair
\n Andy Shing-Fung Chan<\/em>, W\u00fcrzburg Institute of Systems Immunology<\/td>\n <\/tr>\n
10:15 – 10:30<\/td>\n T54 – Napari-organoid-counter: An open-source tool for high-throughput organoid detection in brightfield microscopy
\n Christina Bukas<\/em>, Helmholz Munich<\/td>\n <\/tr>\n
10:30 – 11:00
\n CC & Build23<\/span><\/td>\n 		Break time \/ Industry exhibition<\/span>                                           supported by Qkine<\/span><\/span><\/td>\n <\/tr>\n
11:00 – 12:30<\/td>\n Concurrent strategic working group session<\/strong><\/td>\n <\/tr>\n
11:00 – 12:30
\n Plenary Hall<\/td>\n 		Technologies in stem cell research<\/b>                      supported by iotaSciences<\/span><\/span>
\n Chairs: Sebastian Diecke & Ole Pless<\/em><\/td>\n <\/tr>\n
11:05 – 11:25<\/td>\n S1 – Reproducible brain organoids for disease phenotyping and screening
\n Jakob Metzger<\/em>, Max Delbr\u00fcck Center, Berlin<\/td>\n <\/tr>\n
11:25 – 11:45<\/td>\n S2 – High-content phenotypic profiling reveals subpopulation-specific modulation of human microglia by inflammasome-targeting compounds
\n Johannes Wilbertz<\/em>, Ksilink, Strasbourg, France<\/td>\n <\/tr>\n
11:45 – 12:05<\/td>\n S3 – Bioreactor-based innate immunocompetent hiPSC-derived neurospheroids as preclinical models for advanced therapy development
\n Catarina Brito<\/em>, iBet, Qeiras, Portugal<\/td>\n <\/tr>\n
12:05 – 12:25<\/td>\n S4 – BMP, MEK and WNT inhibition: A novel dSMAD-independent paradigm for rapid generation of hiPSC-derived neurons amenable to regional patterning
\n Peter Reinhardt<\/em>, Abbvie, Ludwighafen<\/td>\n <\/tr>\n
11:00 – 12:30
\n SR1050<\/td>\n 		Career development<\/strong>
\n Chairs:  Marieke Essers & Karin Hoehne<\/em><\/td>\n <\/tr>\n
 <\/td>\n S5 – Stay calm and clear: Communication strategies for difficult situations
\n Nele Haasen<\/em>, konteam, Munich<\/td>\n <\/tr>\n
11:00 – 12:30
\n LH23<\/td>\n 		Clinical trials & regulatory affairs<\/strong>
\n Chairs: Andreas Kurtz & Torsten Tonn<\/em><\/td>\n <\/tr>\n
11:00 – 11:30<\/td>\n S6 – iPSC banks for clinical use: Regulatory and ethical challenges and solutions from the perspective of EU COST Action HAPLOiPS and the Norwegian iPSC Biobank for Clinical Applications (NIBCA)
\n Joel C. Glover<\/em>, Norwegian Center for Stem Cell Research, Oslo, Norway <\/td>\n <\/tr>\n
11:30 – 12:00<\/td>\n S7 – tba
\n Joannis Mytilineos<\/em>, German National Bone Marrow Donor Registry (ZKRD), Ulm<\/td>\n <\/tr>\n
12:00 – 12:30<\/td>\n S8 – Applying haplo-selected hiPSC lines and safety switches: Significant steps towards safer ‚off-the-shelf‘ iPSC-based ATMPs
\n Gerald G. Schumann<\/em>, Paul-Ehrlich-Institut, Langen<\/td>\n <\/tr>\n
12:30 – 14:00
\n Mensa <\/span><\/td>\n 		Lunch break time \/ Industry exhibition<\/span>           supported by Stem Genomics<\/span><\/span><\/td>\n <\/tr>\n
14:00 – 14:45
\n Plenary Hall<\/td>\n 		Keynote lecture IV<\/strong>
\n K4 – From bench to bedside: Chemical reprogramming and the future of regenerative medicine
\n Hongkui Deng<\/em>, Peking University (PKU), Beijing, China
\n Chair: tba<\/em><\/td>\n <\/tr>\n
14:45 – 15:35
\n Plenary Hall<\/td>\n 		Keynote lecture V & Pro-Scientia-Award ceremony<\/strong>
\n K5 – Epigenetic mechanisms of cellular plasticity
\n Maria Elena Torres-Padilla<\/em>, Helmholtz Munich
\n Chair: Ana Martin-Villalba<\/i>
\n Award ceremony: Annette Schmidt-Buddecke<\/em> & Christoph Peters<\/em>, Eckhart-Buddecke-Stiftung<\/td>\n <\/tr>\n
\n

15:35 – 15:50
\n Plenary Hall<\/p>\n <\/td>\n

Award ceremony<\/strong>
\n Daniel Besser<\/i>
\n Poster awards                               supported by Active Bioscience (AB) \/ Pepti<\/span><\/span>Growth (PG)<\/span><\/span> <\/i>
\n Travel awards<\/td>\n <\/tr>\n
15:50 – 16:00
\n Plenary Hall<\/td>\n 		Closing remarks by the GSCN president<\/strong>
\n Heiko Lickert <\/i><\/td>\n <\/tr>\n
 <\/td>\n End of GSCN Conference 2025<\/strong><\/span><\/td>\n <\/tr>\n <\/tbody>\n
 <\/td>\n Top<\/a><\/td>\n <\/tr>\n <\/tbody>\n<\/table>\n<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Keynote Speakers 2025<\/h3>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\"\"<\/a><\/strong>
\nHongkui Deng<\/a> <\/strong> (Beijing, China)<\/p>\n\n

\"\"<\/a><\/strong>
\nJacob Hanna<\/a> <\/strong> (Rehovot, Israel)<\/p>\n\n

\"\"<\/a><\/strong>
\nTimm Schroeder<\/a><\/strong> (Basel, Switzerland)<\/p>\n\n

\"\"<\/a><\/strong>
\nViviane Tabar\u200b<\/strong><\/a> (New York City, USA)<\/p>\n\n

\"\"<\/a><\/strong>
\nMaria-Elena Torres-Padilla<\/a><\/strong> (Munich, Germany)<\/p>\n\n

\"\"<\/a><\/strong>
\nWolfram-Hubertus Zimmermann<\/strong><\/a> (G\u00f6ttingen, Germany)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Speakers & Session Chairs<\/h3>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Sina Bartfeld<\/a> (Berlin)
\nDaniel Besser<\/a> (Berlin)
\nThomas Braun<\/a> (Bad Nauheim)
\nOliver Br\u00fcstle<\/a> (Bonn)
\nNina Cabezas Wallscheid<\/a> (Freiburg)
\nGerm\u00e1n Camargo-Ortega<\/a> (Basel)
\nTobias Cantz<\/a> (Hannover)
\nMichael Cross <\/a>(Leipzig)
\nSebastian Diecke<\/a> (Berlin)
\nMicha Drukker<\/a> (Leiden, NL)
\nMarieke Essers<\/a> (Heidelberg)
\nHartmut Geiger<\/a> <\/a>(Ulm)
\nIngmar Glauche<\/a> (Dresden)
\nMina Gouti<\/a> (Berlin)
\nAnne Grapin-Botton<\/a> (Dresden)
\nSimon Haas<\/a> (Berlin)
\nIra Herrmann<\/a> (Bonn)
\nZolt\u00e1n Ivics<\/a> (Langen)
\nRalf Jauch<\/a> (Hongkong) supported by Centre for Translational Stem Cell Biology (CTSCB), Hong Kong<\/a><\/span><\/span>
\nBert Klebl<\/a> (Dortmund)
\nHannes Klump<\/a> (Essen)
\nAndreas Kurtz<\/a> (Berlin)
\nKarl-Ludwig Laugwitz<\/a> (Munich)
\nHeiko Lickert<\/a> (Munich)
\nCarsten Marr<\/a> (Munich)
\nUlrich Martin<\/a> (Hannover)
\nAna Martin-Villalba<\/a> (Heidelberg)
\nElvira Mass<\/a> (Bonn)
\nMick Milsom<\/a> (Heidelberg)
\nMichael Rieger<\/a> (Frankfurt a.M.)
\nHans Sch\u00f6ler<\/a> <\/a>(M\u00fcnster)
\nInsa Schr\u00f6der<\/a> (Darmstadt)
\nThomas Schwarz-Romond<\/a> (Munich)
\nHarald Stachelscheid<\/a> (Berlin)
\nLaura Steenpa\u00df<\/a> (Braunschweig)
\nTorsten Tonn<\/a> (Dresden)
\nAnja Trillhaase<\/a> (Hamburg)
\nWolfgang Wagner<\/a> (Aachen)
\nClaudia Waskow<\/a> (Jena)
\nRobert Zweigerdt<\/a> (Hannover)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\"\"<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\"\"<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\"\"<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\"\"<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\"email<\/a><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\"twitter\"<\/a><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\"GSCN\"<\/a><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\"Youtube\"<\/a><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\"\"<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Gold Supporters<\/h2>\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Silver Supporters<\/h2>\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Bronze Supporters<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\"sl-bio-lima\"<\/figure><\/div>
\"Biomerieux_Logo_400x240\"<\/figure><\/div>
\"bio-techne_Logo_400x282\"<\/figure><\/div>
\"Evotec_Logo_400x282\"<\/figure><\/div>
\"IDT_Logo_400x282\"<\/figure><\/div>
\"IotaSciences_Logo_400x282\"<\/figure><\/div>
\"Miltenyi_Logo_400x282\"<\/figure><\/div>
\"Minaris_Logo_400x282\"<\/figure><\/div>
\"OLS_Logo_400x282\"<\/figure><\/div>
\"Qkine_Logo_400x282\"<\/figure><\/div>
\"Sartorius_Logo_400x282\"<\/figure><\/div>
\"StemGenomics_logo_400x282\"<\/figure><\/div>
\"ThermoFisherScientific_logo_2023_400x282\"<\/figure><\/div>\t\t\t<\/div>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Academic Supporters<\/h1>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\"Helmholtz_Munich_Logo_400x282\"<\/figure><\/div>
\"DFG_Logo_400x282\"<\/figure><\/div>
\"BIH2021_Logo_400x282\"<\/figure><\/div>
\"Logo_TACTiC_400x240\"<\/figure><\/div>
\"Logo_DZL_Breath_400x240\"<\/figure><\/div>
\"Logo_DZD_Diabetes_400x282\"<\/figure><\/div>\t\t\t<\/div>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":136,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-777","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/gscn.sleware.com\/gscn-conferences\/wp-json\/wp\/v2\/pages\/777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gscn.sleware.com\/gscn-conferences\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gscn.sleware.com\/gscn-conferences\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gscn.sleware.com\/gscn-conferences\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gscn.sleware.com\/gscn-conferences\/wp-json\/wp\/v2\/comments?post=777"}],"version-history":[{"count":1,"href":"https:\/\/gscn.sleware.com\/gscn-conferences\/wp-json\/wp\/v2\/pages\/777\/revisions"}],"predecessor-version":[{"id":778,"href":"https:\/\/gscn.sleware.com\/gscn-conferences\/wp-json\/wp\/v2\/pages\/777\/revisions\/778"}],"up":[{"embeddable":true,"href":"https:\/\/gscn.sleware.com\/gscn-conferences\/wp-json\/wp\/v2\/pages\/136"}],"wp:attachment":[{"href":"https:\/\/gscn.sleware.com\/gscn-conferences\/wp-json\/wp\/v2\/media?parent=777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}